Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

6.12
-0.6200-9.20%
Post-market: 6.11-0.0100-0.16%19:57 EST
Volume:5.90M
Turnover:36.00M
Market Cap:1.02B
PE:-58.63
High:6.62
Open:6.51
Low:5.80
Close:6.74
52wk High:10.08
52wk Low:3.59
Shares:165.92M
Float Shares:159.00M
Volume Ratio:3.46
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1044
EPS(LYR):-0.3736
ROE:-617.16%
ROA:2.88%
PB:-1179.39
PE(LYR):-16.38

Loading ...

Earning Preview: Xeris Pharmaceuticals Inc Q1 revenue is expected to increase by 41.71%, and institutional views are constructive

Earnings Agent
·
Feb 23

A Look At Xeris Biopharma Holdings (XERS) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Feb 28

Why Are Shares Of Xeris Biopharma Falling Friday?

Benzinga_recent_news
·
Feb 28

BRIEF-Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit

Reuters
·
Feb 27

Xeris Biopharma Subsidiaries Sue Torrent and Somerset Over Recorlev Patents Through 2040

Reuters
·
Feb 27

Xeris Biopharma Holdings Inc: Intends to Enforce and Defend Its Intellectual Property Rights Relating to Recorlev

THOMSON REUTERS
·
Feb 27

Xeris Biopharma Holdings Inc. published an update to their financial calendar

Reuters
·
Feb 17

Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026

THOMSON REUTERS
·
Feb 17

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Updated 2025 Revenue Outlook

Simply Wall St.
·
Jan 18

Xeris Biopharma President and COO Kevin McCulloch Reports Disposal of Common Shares

Reuters
·
Jan 10

Xeris Biopharma Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 09

Xeris Biopharma Expects 2025 Revenue to Reach $292 Million

Reuters
·
Jan 08

Xeris Biopharma Holdings Inc - Expects 2025 Revenue of $292 Mln, Exceeding Guidance

THOMSON REUTERS
·
Jan 08

Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue

THOMSON REUTERS
·
Jan 08

Xeris Biopharma Holdings Inc. Officer John Patrick Shannon Jr. Reports Disposal of Common Shares

Reuters
·
Jan 07

Xeris Biopharma Officer Beth Hecht Reports Sale of Common Shares

Reuters
·
Jan 06

BRIEF-Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 03

Xeris Biopharma Grants 181,550 Restricted Stock Units to New Employees

Reuters
·
Jan 03

Have Xeris Biopharma Holdings Insiders Been Selling Stock?

Simply Wall St.
·
Dec 22, 2025

Director John Johnson Reports Sale of Xeris Biopharma Holdings Inc. Common Shares

Reuters
·
Dec 20, 2025